These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres. Francisco EC, de Almeida Junior JN, de Queiroz Telles F, Aquino VR, Mendes AVA, de Andrade Barberino MGM, de Tarso O Castro P, Guimarães T, Hahn RC, Padovan ACB, Chaves GM, Colombo AL. Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116 [Abstract] [Full Text] [Related]
3. Intergenic spacer (IGS-1) region sequence-based identification, genotypic analysis, and antifungal susceptibility of clinical Trichosporon species. Parashar A, Rastogi V, Prakash H, Pandey A, Rudramurthy SM. Indian J Med Microbiol; 2023 Jul; 45():100390. PubMed ID: 37573054 [Abstract] [Full Text] [Related]
4. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. Chagas-Neto TC, Chaves GM, Melo AS, Colombo AL. J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102 [Abstract] [Full Text] [Related]
5. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients. Kuo SH, Lu PL, Chen YC, Ho MW, Lee CH, Chou CH, Lin SY. J Formos Med Assoc; 2021 Sep; 120(9):1686-1694. PubMed ID: 33358563 [Abstract] [Full Text] [Related]
6. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B. Iturrieta-González IA, Padovan AC, Bizerra FC, Hahn RC, Colombo AL. PLoS One; 2014 Sep; 9(10):e109553. PubMed ID: 25360765 [Abstract] [Full Text] [Related]
7. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. Sun W, Su J, Xu S, Yan D. J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749 [Abstract] [Full Text] [Related]
8. Invasive Infections Due to Trichosporon: Species Distribution, Genotyping, and Antifungal Susceptibilities from a Multicenter Study in China. Guo LN, Yu SY, Hsueh PR, Al-Hatmi AMS, Meis JF, Hagen F, Xiao M, Wang H, Barresi C, Zhou ML, de Hoog GS, Xu YC. J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892 [Abstract] [Full Text] [Related]
9. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients. Xia Z, Yang R, Wang W, Cong L. Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867 [Abstract] [Full Text] [Related]
10. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina. Taverna CG, Córdoba S, Murisengo OA, Vivot W, Davel G, Bosco-Borgeat ME. Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113 [Abstract] [Full Text] [Related]
13. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species. do Espírito Santo EPT, Monteiro RC, da Costa ARF, Marques-da-Silva SH. Mycopathologia; 2020 Apr; 185(2):307-317. PubMed ID: 31776790 [Abstract] [Full Text] [Related]
14. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Ruan SY, Chien JY, Hsueh PR. Clin Infect Dis; 2009 Jul 01; 49(1):e11-7. PubMed ID: 19489711 [Abstract] [Full Text] [Related]
15. Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis. Padovan ACB, Rocha WPDS, Toti ACM, Freitas de Jesus DF, Chaves GM, Colombo AL. Fungal Genet Biol; 2019 Dec 01; 133():103267. PubMed ID: 31513917 [Abstract] [Full Text] [Related]
16. First genotype identification of Trichosporon asahii in Sfax, Tunisia. Sellami H, Trabelsi H, Neji S, Amouri I, Cheikhrouhou F, Makni F, Ayadi A. J Med Microbiol; 2017 Apr 01; 66(4):397-401. PubMed ID: 28141498 [Abstract] [Full Text] [Related]
17. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin. Mariné M, Bom VL, de Castro PA, Winkelstroter LK, Ramalho LN, Brown NA, Goldman GH. Virulence; 2015 Apr 01; 6(5):476-86. PubMed ID: 25751127 [Abstract] [Full Text] [Related]
18. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Rodriguez-Tudela JL, Gomez-Lopez A, Alastruey-Izquierdo A, Mellado E, Bernal-Martinez L, Cuenca-Estrella M. Diagn Microbiol Infect Dis; 2007 Aug 01; 58(4):435-40. PubMed ID: 17509802 [Abstract] [Full Text] [Related]
19. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples. Ahangarkani F, Ilkit M, Vaseghi N, Zahedi N, Zomorodian K, Khodavaisy S, Afsarian MH, Abbasi K, de Groot T, Meis JF, Badali H. Mycoses; 2021 Aug 01; 64(8):918-925. PubMed ID: 33998718 [Abstract] [Full Text] [Related]
20. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients. Almeida AA, Crispim Bdo A, Grisolia AB, Svidzinski TI, Ortolani LG, Oliveira KM. Rev Argent Microbiol; 2016 Aug 01; 48(1):62-6. PubMed ID: 26916812 [Abstract] [Full Text] [Related] Page: [Next] [New Search]